Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimicoxib plus sertraline vs sertraline plus placebo in major depression
2007-001335-54Phase 2Completed
- Sponsor
- Affectis Pharmaceuticals AG
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline + cimicoxib with Sertraline + placebo (2 arms). Primary endpoint: Change in HamD-17 total score from baseline to week 6. Started Jun 2007; status: completed.
02
Drugs
cimicoxib
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-001335-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001335-54.